Obesity Clinical Trial
Official title:
Guelph Family Health Study: Pilot Study
Verified date | January 2017 |
Source | University of Guelph |
Contact | n/a |
Is FDA regulated | No |
Health authority | Canada: Ethics Review Committee |
Study type | Interventional |
The overall objective of the proposed study is to test, among Canadian families, the
comparative effectiveness of 2 different versions (doses) of a family-based obesity
prevention intervention that is tailored to families' behavioural risk profile.
To achieve this objective, we will conduct a randomized controlled trial of families with
children aged 18 months- 5 years. Families will be randomized to 1 of 3 conditions: 1)
Monthly emails with general health information (Attention Control), 2) Tailored weekly
emails and 2 home visits with a health educator (Email +2), 3) Tailored weekly emails and 4
home visits (Email +4). The intervention will last 6 months, with follow-up at 12-months
post-intervention (18 months from baseline). We will examine the impact of the intervention
on the children's body composition, weight-related behaviours, and biomarkers of diabetes
and cardiovascular disease risk.
We hypothesize that, compared to children in the Attention Control, children in the Email +2
and Email +4 conditions will achieve:
1. a smaller increase in adiposity (primary outcome), age- and gender-specific body mass
index (BMI),over a 6-month intervention period.
2. higher frequency of family meals, child's sleep duration, physical activity, and fruit
and vegetable intake and lower child's sugar-sweetened beverage intake, and sedentary
behaviour over a 6-month intervention period. (secondary outcomes)
3. lower diastolic blood pressure, glycosylated hemoglobin, fasting glucose, fasting
insulin, Low Density Lipoprotein (LDL) cholesterol, triglycerides, C-reactive protein,
trans and saturated fats, and higher High Density Lipoprotein (HDL) cholesterol over a
6-month intervention period.
We further hypothesize that there will be no significant difference in these outcomes
between children in the conditions with 2 (Email +2) or 4 (Email +4) home visits.
Status | Completed |
Enrollment | 44 |
Est. completion date | December 2016 |
Est. primary completion date | March 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - families who have a child aged 18 months through 5 years - live the Guelph area - have a parent who can respond to questionnaires in English Exclusion Criteria: - families who plan to move during the study period - children with severe health conditions (such as severe cerebral palsy) that would prohibit them from participating in study activities |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
Canada | Univeristy of Guelph | Guelph | Ontario |
Lead Sponsor | Collaborator |
---|---|
University of Guelph |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | change in adiposity | baseline, 6 month follow-up | No | |
Secondary | change in body mass index | baseline, 6-month follow-up | No | |
Secondary | change in waist circumference | baseline, 6-month follow-up | No | |
Secondary | change in frequency of family meals | baseline, 6-month follow-up | No | |
Secondary | change in child's sleep duration | baseline, 6-months | No | |
Secondary | change in child's physical activity | baseline, 6-months | No | |
Secondary | change in child's fruit and vegetable intake | baseline, 6-month follow-up | No | |
Secondary | change in child's sugar-sweetened beverage intake | baseline, 6-month follow-up | No | |
Secondary | change in sedentary behaviour | baseline, 6-month follow-up | No | |
Secondary | change in child's diastolic blood pressure | baseline, 6-month follow-up | No | |
Secondary | change in child's biomarkers of diabetes and cardiovascular disease risk | baseline, 6-month follow-up | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |